Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Gall Bladder Diseases

fluorodeoxyglucose f18 has been researched along with Gall Bladder Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, R; Mittal, BR; Parihar, AS; Rana, S; Singh, H; Singh, S; Vadi, SK1
Kim, CK; Kim, KS; Lee, J; Lee, JD; Yun, M1
Koh, T; Kunishima, S; Taniguchi, H; Yamagishi, H; Yamaguchi, A1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Gall Bladder Diseases

ArticleYear
18F-FDG PET/CT in an Atypical Case of Relapsed IgG4-Related Disease Presenting as Inflammatory Pseudotumor in Gall Bladder Fossa With Extensive Disease Involvement.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:10

    Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Diseases; Humans; Immunoglobulin G; Inflammation; Male; Positron Emission Tomography Computed Tomography; Recurrence

2018
Risk stratification of gallbladder polyps (1-2 cm) for surgical intervention with 18F-FDG PET/CT.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:3

    Topics: Adenocarcinoma; Adenoma; Adult; Aged; Cell Transformation, Neoplastic; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallbladder Diseases; Gallbladder Neoplasms; Gallstones; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Polyps; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Tomography, Emission-Computed

2012
Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET).
    Journal of surgical oncology, 2003, Volume: 84, Issue:2

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Cholecystitis; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gallbladder Diseases; Gallbladder Neoplasms; Humans; Middle Aged; Polyps; Radiopharmaceuticals; Tomography, Emission-Computed

2003